Education
About Us
Working with TipRanks
Follow Us
Jennifer Jarrett Insider Profile
4 Followers
Jennifer Jarrett, Chief Financial Officer at Medivation, holds 193.02K shares in Arcus Biosciences (Ticker: RCUS), holds 90.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 0.00 shares in Arena Pharma (Ticker: ARNA). Most recently, Jennifer Jarrett Sold ― shares of Arcus Biosciences on Dec 18, 2025 for an estimated value of $466.73K.
Jennifer Jarrett Medivation (MDVN)Chief Financial Officer
Medivation (MDVN)
Chief Financial Officer
Ranked #7,315 out of 105,219 Corporate Insiders
Profitable Transactions
7 out of 10 Profitable Transactions
Average Return
+26.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer Jarrett holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jennifer Jarrett
Jennifer Jarrett's Trading History
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$0.00
Arena Pharma
Mar 11, 2022
―
Uninformative Sell
―
$0.00
Audentes Therapeutics
―
―
―
―
Arcus Biosciences
Dec 18, 2025
COO
Informative Sell
466.73K
$4.30M
Syndax Pharmaceuticals
Feb 07, 2025
Director
Uninformative Buy
―
$1.83M
Surrozen
Aug 13, 2021
Former Director
Uninformative Buy
―
$625.50K
Radius Health
―
―
―
―
Zura Bio
―
Director
―
―
Sagimet Biosciences, Inc. Class A
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jennifer Jarrett's performance on stock
You May Also Like
Jennifer Jarrett insider profile FAQ
What is the percentage of profitable transactions made by Jennifer Jarrett?
The percentage of profitable transactions made by Jennifer Jarrett is 70%.
What is the average return per transaction made by Jennifer Jarrett?
The average return per transaction made by Jennifer Jarrett is 26.10%.
What stocks does Jennifer Jarrett hold?
Jennifer Jarrett holds: MDVN, ARNA, ~BOLD, RCUS, SNDX, SRZN, ~RDUS, ZURA, SGMT stocks.
What was Jennifer Jarrett’s latest transaction?
Jennifer Jarrett latest transaction was an Informative Sell of $466.73K.
What was Jennifer Jarrett's most profitable transaction?
Jennifer Jarrett’s most profitable transaction was an Informative Sell of RCUS stock on March 18, 2022. The return on the trade was 54.20%.
What is Jennifer Jarrett's role in Medivation?
Jennifer Jarrett's role in Medivation is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.